33858415|t|Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis.
33858415|a|BACKGROUND: Lung adenocarcinoma (LUAD) metastasis significantly reduces patient survival; hence inhibiting the metastatic ability of lung cancer cells will greatly prolong patient survival. Alkaline phosphatase (ALPL), a homodimeric cell surface phosphohydrolase, is reported to play a controversial role in prostate cancer and ovarian cancer cell migration; however, the function of ALPL in LUAD and the related mechanisms remain unclear. METHODS: TCGA database was used to analysis the expression of ALPL, and further verification was performed in a cohort of 36 LUAD samples by qPCR and western blot. Soft-agar assay, transwell assay and lung metastasis assay were employed to detect the function of ALPL in LUAD progression. The qPCR, luciferase promoter reporter assay and western blot were used to clarify the molecular mechanisms of ALPL in promoting metastasis in LUAD. RESULTS: ALPL was downregulated in LUAD, and the disease-free survival rate of patients with low ALPL was significantly reduced. Further studies showed that overexpression of ALPL in LUAD cell lines did not significantly affect cell proliferation, but it did significantly attenuate lung metastasis in a mouse model. ALPL downregulation in LUAD led to a decrease in the amount of phosphorylated (p)-ERK. Because p-ERK promotes the classical c-Myc degradation pathway, the decrease in p-ERK led to the accumulation of c-Myc and therefore to an increase in RhoA transcription, which enhanced LUAD cell metastasis. CONCLUSION: ALPL specially inhibits the metastasis of LUAD cells by affecting the p-ERK/c-Myc/RhoA axis, providing a theoretical basis for the targeted therapy of clinical LUAD.
33858415	45	75	lung adenocarcinoma metastasis	Disease	MESH:D000077192
33858415	84	89	c-Myc	Gene	4609
33858415	90	94	RhoA	Gene	387
33858415	113	134	Lung adenocarcinoma (	Disease	MESH:D000077192
33858415	134	150	LUAD) metastasis	Disease	MESH:D000077192
33858415	173	180	patient	Species	9606
33858415	234	245	lung cancer	Disease	MESH:D008175
33858415	273	280	patient	Species	9606
33858415	313	317	ALPL	Gene	249
33858415	409	424	prostate cancer	Disease	MESH:D011471
33858415	429	443	ovarian cancer	Disease	MESH:D010051
33858415	485	489	ALPL	Gene	249
33858415	603	607	ALPL	Gene	249
33858415	742	757	lung metastasis	Disease	MESH:D009362
33858415	804	808	ALPL	Gene	249
33858415	941	945	ALPL	Gene	249
33858415	959	969	metastasis	Disease	MESH:D009362
33858415	988	992	ALPL	Gene	249
33858415	1058	1066	patients	Species	9606
33858415	1076	1080	ALPL	Gene	249
33858415	1154	1158	ALPL	Gene	249
33858415	1262	1277	lung metastasis	Disease	MESH:D009362
33858415	1283	1288	mouse	Species	10090
33858415	1296	1300	ALPL	Gene	249
33858415	1378	1381	ERK	Gene	5594
33858415	1393	1396	ERK	Gene	5594
33858415	1420	1425	c-Myc	Gene	4609
33858415	1465	1468	ERK	Gene	5594
33858415	1496	1501	c-Myc	Gene	4609
33858415	1534	1538	RhoA	Gene	387
33858415	1579	1589	metastasis	Disease	MESH:D009362
33858415	1603	1607	ALPL	Gene	249
33858415	1631	1641	metastasis	Disease	MESH:D009362
33858415	1675	1678	ERK	Gene	5594
33858415	1679	1684	c-Myc	Gene	4609
33858415	1685	1689	RhoA	Gene	387
33858415	Association	MESH:D000077192	4609
33858415	Association	MESH:D000077192	387
33858415	Negative_Correlation	249	5594
33858415	Association	249	4609
33858415	Association	MESH:D000077192	249
33858415	Association	MESH:D009362	5594
33858415	Association	387	5594
33858415	Negative_Correlation	MESH:D009362	249
33858415	Association	MESH:D009362	387
33858415	Association	387	4609
33858415	Association	MESH:D011471	249
33858415	Association	249	387
33858415	Association	4609	5594

